Insights Into Chronic Lymphocytic Leukemia (CLL) 2021
Perspectives of community physicians from across the US on the management of newly diagnosed and relapsed/refractory CLL
Faculty Chair
Susan O’Brien, MD
UC Irvine Medical Center, Orange County, CA
Faculty Chair
Ian Flinn, MD
Tennessee Oncology, Nashville, TN
Faculty Chair
John Allan, MD
Weill Cornell Medicine, New York, NY
Faculty Chair
Susan O'Brien, MD
UC Irvine Medical Center, Orange County, CA
Faculty Chair
Steven Coutre, MD
Stanford Cancer Center, Palo Alto, CA
Faculty Chair
Sameer Parikh, MD
Mayo Clinic, Rochester, MN
Faculty Chair
Susan O’Brien, MD
UC Irvine Medical Center, Orange County, CA
More Information
- Virtual Series
- Southern California, Nevada, Utah, Arizona, New Mexico, Colorado
More Information
- Virtual Series
- Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia
More Information
- Virtual Series
- New York, Tennessee
More Information
- Virtual Series
- Connecticut, Delaware, DC, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont
More Information
- Virtual Series
- Texas, Arizona, California
More Information
- Virtual Series
- Illinois, Iowa, Nebraska, North Dakota, South Dakota, Minnesota, Wisconsin, Michigan, Indiana, Ohio
More Information
- Virtual Series
- Northern California, Oregon, Washington, Idaho, Montana, Wyoming
REPORT SNAPSHOT
- A virtual, moderated roundtable discussion focusing on the treatment of chronic lymphocytic leukemia
- Disease state and data presentations are developed in conjunction with a national or regional oncology expert
- Insights on the following therapies will be obtained: acalabrutinib, ibrutinib, zanubrutinib, obinutuzumab, rituximab, venetoclax, duvelisib, idelalisib, FCR, and BR
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection is accomplished through use of audience response system questioning and moderated discussion
- The group of advisors will comprise 10–15 medical oncologists representative of each region
